Abstract
Raynaud’s phenomenon (RP) is a vasospastic disorder characterized by episodic color changes of blanching, cyanosis, and hyperaemia in response to cold and/or emotional stress. Although most typically noted in the fingers, circulation of the toes, ears, nose and tongue is also frequently affected. Population studies have shown that RP in adults is more common in women than in men, with prevalence estimates ranging from 4% to 30%. Geographic variations in the prevalence reflect differences in climate.
RP may be a primary or a secondary process. LeRoy and Medsger suggested criteria for primary RP: symmetric attacks, the absence of tissue necrosis, ulceration or gangrene, the absence of a secondary cause, negative antinuclear antibodies, normal nailfold capillaroscopy and a normal erythrocyte sedimentation rate. Among the CTDs, systemic sclerosis has the highest frequency of RP.
Finding a cause for RP requires a knowledge of the patient’s occupational, smoking and drug history, physical examination, nailfold capillaroscopy, routine laboratory tests and autoantibodies. Furthermore, RP should be distinguished from acrocyanosis, a condition characterized by continuous cyanosis of the hands or feet that is worsened by cold temperature.’
Similar content being viewed by others
Bibliografia
Wigley FM (2002) Raynaud’s phenomenon. N Engl J Med 347:1001–1008
Zeni S, Ingegnoli F (2004) Il fenomeno di Raynaud. Reumatismo 56:79–83
Maricq HR, Weinrich MC (1988) Diagnosis of Raynaud’s phenomenon assisted by color charts. J Rheumatol 15:454–459
Olsen N, Nielsen SL (1978) Prevalence of primary Raynaud phenomena in young females. Scand J Clin Lab Invest 38:761–764
Weinrich MC, Maricq HR, Keil JE et al (1990) Prevalence of Raynaud phenomenon in the adult population of South Carolina. J Clin Epidemiol 43:1343–1349
Fraenkel L, Zhang Y, Chaisson CE et al (1999) Different factors influencing the expression of Raynaud’s phenomenon in men and women. Arthritis Rheum 42:306–310
Keil JE, Maricq HR, Weinrich MC et al (1991) Demographic, social and clinical correlates of Raynaud phenomenon. Int J Epidemiol 20:221–224
Riera G, Vilardell M, Vaqué J et al (1993) Prevalence of Raynaud’s phenomenon in Raya healthy Spanish population. J Rheumatol 20:66–69
Maricq HR, Carpentier PH, Weinrich MC et al (1997) Geographic variation in the prevalence of Raynaud’s phenomenon: a 5 region comparison. J Rheumatol 24:879–889
Grassi W, Lapadula G, Leardini G, Scarpa R; Gruppo italiano per lo studio del fenomeno di Raynaud (GISFER) (1995) Il fenomeno di Raynaud. Lineamenti clinici e demografici. Reumatismo 47:1–11
Gallo E, Bianchi E, Motta A, Piccolo N (1994) Incidenza del fenomeno di Raynaud in 1920 residenti in Milano. Minerva Cardioangiol 42:65–71
Watson HR, Robb R, Belcher G, Belch JJ (1999) Seasonal variation of Raynaud’s phenomenon secondary to systemic sclerosis. J Rheumatol 26:1734–1737
Brown KM, Middaugh SJ, Haythornthwaite JA, Bielory L (2001) The effects of stress, anxiety and outdoor temperature on the frequency and severity of Raynaud’s attacks: the Raynaud’s Treatment Study. J Behav Med 24:137–153
Jones GT, Herrick AL, Woodham SE et al (2003) Occurrence of Raynaud’s phenomenon in children ages 12–15 years: prevalence and association with other common symptoms. Arthritis Rheum 48:3518–3521
Planchon B, Pistorius MA, Beurrier P, De Faucal P (1994) Primary Raynaud’s phenomenon. Age of onset and pathogenesis in a prospective study of 424 patients. Angiology 45:677–686
Raynaud’s Treatment Study Investigators (2000) Comparison of sustained release nifedipine and temperature biofeedback for treatment of primary Raynaud phenomenon. Results from a randomised clinical trial with 1 year follow-up. Arch Intern Med 160:1101–1108
Freedman RR, Mayes MD (1996) Familial aggregation of primary Raynaud’s disease. Arthritis Rheum 39:1189–1191
Kallenberg CG (1990) Early detection of connective tissue disease in patients with Raynaud’s phenomenon. Rheum Dis Clin North Am 16:11–30
Matucci Cerinic M, Kahaleh B, LeRoy EC (1996) Vascular involvement in systemic sclerosis. In: Clements PJ, Furst DE (Eds.) Systemic sclerosis, 1st ed. Williams & Wilkins, Baltimore: 153–174
Johnson S, Iazzetta J, Dewar C (2003) Severe Raynaud’s phenomenon with yohimbine therapy for erectile dysfunction. J Rheumatol 30:2503–2505
LeRoy EC, Medsger TA (1992) Raynaud’s phenomenon: a proposal for classification. Clin Exp Rheumatol 10:485–488
Spencer-Green G (1998) Outcomes in primary Raynaud phenomenon: a metaanalysis of the frequency, rates, and predictors of transition to secondary diseases. Arch Intern Med 158:595–600
Kallenberg CG, Wouda AA, Hoet MH, van Venrooij WJ (1988) Development of connective tissue disease in patients presenting with Raynaud’s phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting. Ann Rheum Dis 47:634–641
Wollersheim H, Thien T, Hoet MH, van Venrooij WJ (1989) The diagnostic value of several immunological tests for anti-nuclear antibody in predicting the development of connective tissue disease in patients presenting with Raynaud’s phenomenon. Eur J Clin Invest 19:535–541
Harper FE, Maricq HR, Turner RE et al (1982) A prospective study of Raynaud phenomenon and early connective tissue disease. A five-year report. Am J Med 72:883–888
Zufferey P, Depairon M, Chamot AM, Monti M (1992) Prognostic significance of nailfold capillary microscopy in patients with Raynaud’s phenomenon and scleroderma-pattern abnormalities. A six-year follow-up study. Clin Rheumatol 11:536–541
Faravelli C, Zeni S, Cirla E, Fantini F (1990) Gli autoanticorpi anticentromero e anti-Scl 70 nell’inquadramento diagnostico della sclerodermia. Reumatismo 2:115–124
Luggen M, Belhorn L, Evans T et al (1995) The evolution of Raynaud’s phenomenon: a longterm prospective study. J Rheumatol 22:2226–2232
Cutolo M, Grassi W, Matucci Cerinic M (2003) Raynaud’s phenomenon and the role of capillaroscopy. Arthritis Rheum 48:3023–3030
Author information
Authors and Affiliations
About this article
Cite this article
Zeni, S. Il fenomeno di Raynaud: diagnostica. Arch Ortop Reumatol 121, 10–11 (2010). https://doi.org/10.1007/s10261-010-0004-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10261-010-0004-0